Page last updated: 2024-08-21

fluorobenzenes and Angiitis

fluorobenzenes has been researched along with Angiitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Debanne, SM; Eckard, AR; Funderburg, NT; Jiang, Y; McComsey, GA1
Dubé, MP1
Clagett, B; Debanne, SM; Ferrari, B; Funderburg, NT; Jiang, Y; Juchnowski, S; Labbato, D; Lederman, MM; McComsey, GA; Robinson, J1
Cremonesi, B; Gelosa, P; Gianazza, E; Gianella, A; Guerrini, U; Nobili, E; Paoletti, R; Sironi, L; Tremoli, E1

Trials

2 trial(s) available for fluorobenzenes and Angiitis

ArticleYear
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.
    The Journal of infectious diseases, 2014, Apr-15, Volume: 209, Issue:8

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anti-Retroviral Agents; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrimidines; Regression Analysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Vasculitis

2014
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2015, Apr-01, Volume: 68, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Antigens, CD; Female; Fluorobenzenes; HIV Infections; HLA-DR Antigens; Humans; Male; Middle Aged; Monocytes; Programmed Cell Death 1 Receptor; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes; Treatment Outcome; Vasculitis

2015

Other Studies

2 other study(ies) available for fluorobenzenes and Angiitis

ArticleYear
Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?
    The Journal of infectious diseases, 2014, Apr-15, Volume: 209, Issue:8

    Topics: Anti-Retroviral Agents; Cardiovascular Diseases; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasculitis

2014
Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:3

    Topics: Acute-Phase Proteins; Animals; Cerebral Arteries; Chemokine CCL2; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; P-Selectin; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sodium Chloride, Dietary; Stroke; Sulfonamides; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vasculitis

2005